TLR4 and schistosomiasis: Although the mesenchymal stem cell (MSC) is being used to treat different immune-disturbance complications, current investigation revealed that TLR4 combined with IFN-γ can activate the MSC group with positive effects on the pathology of schistosomiasis by modulating Th subsets at some degree (Liu et al., 2020).